JMAR Granted $4.2 Million Subcontract to Enhance Semiconductor Operations at DMEA Installation in Sacramento
GDAIS, a prime contractor for the Defense Microelectronics Activity (DMEA), has issued JMAR this subcontract as a Department of Defense (DOD) Advanced Technology Support Program (ATSP) element. In 2005, JMAR received from GDAIS $2.3 million in letter subcontracts against this subcontract. Costs have already been incurred and recognized in 2005 and early 2006 against those letter subcontracts. The costs related to the remaining $1.9 million of funding will be incurred primarily through June 30, 2006.
“This contract marks a continuation of the relationship between JMAR and both General Dynamics and the DMEA. Our Microelectronics team remains fully committed to sustaining and improving the ARMS foundry in accordance with the DMEA vision”
"This contract marks a continuation of the relationship between JMAR and both General Dynamics and the DMEA. Our Microelectronics team remains fully committed to sustaining and improving the ARMS foundry in accordance with the DMEA vision," said Ronald A. Walrod, JMAR's president and chief executive officer.
Under a contract awarded by GDAIS in 1998, JMAR supported the DMEA in the design, construction and commissioning of the ARMS foundry, and since then has played a key role in the installation and implementation of that foundry's chip fabrication processes. JMAR maintains a semiconductor process engineering group adjacent to DMEA's facility in Sacramento. JMAR will perform the work under this contract on-site.
Mr. Walrod concluded, "JMAR's semiconductor process engineering group is unique in its ability to provide the DMEA with the highly specialized, long-term support it needs for the evaluation, selection, installation and implementation of these new semiconductor manufacturing processes. Our support has been instrumental in helping the DMEA fulfill its increasingly vital role in the nation's defense."
About the DMEA
The DOD established the DMEA to solve the problem of microelectronics obsolescence over the extended lifetime of weapon systems. Its mission and capability is recognized as both unique and critical for the DOD as well as for other branches of the U.S. Government, including NASA, the FAA and the Department of Transportation. The DMEA's advanced technology services and facilities are also available on a dual-use basis to the private sector through Cooperative Research and Development Agreements (CRADA). These agreements position the private sector to use those processes aimed at enhancing the ARMS foundry, for commercial product manufacturing.
The ARMS foundry is a custom integrated circuit prototyping facility responsible for producing critical innovative microcircuits to replace obsolete military system electronics, thereby extending the operational lifetimes of those systems for substantial periods with attendant savings to the U.S. Government. The foundry has more than a hundred engineering and support specialists in order to design and develop analog, digital, and mixed signal integrated circuits and hybrid and multi-chip module products.
JMAR Technologies, Inc. is a leading innovator in the development of laser-based equipment for imaging, analysis and fabrication at the nano-scale. The Company is leveraging over a decade of laser and photonics research to develop a diverse portfolio of products with commercial applications in rapidly growing industries while continuing to carry out research and development for the U.S. Defense Advanced Research Projects Agency (DARPA) and support for the U.S. Government's Defense Microelectronics Activity (DMEA) semiconductor fabrication facility. JMAR is targeting the nanotechnology, bioscience and semiconductor industries with its BriteLight(TM) Laser; X-ray Light Source; Compact X-ray Microscope - for 3D visualization of single cells and polymers; and its X-ray Nano Probe - enabling interaction, analysis and materials modification at the nano-scale. JMAR also develops, manufactures and markets its BioSentry(TM) microorganism contamination warning system and maintains a strategic alliance for the production of the READ chemical sensor for homeland security, environmental and utility infrastructure industries.
This news release contains certain "forward-looking statements." Forward-looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company's control. Actual results could differ materially from these forward-looking statements as a result of a number of factors, including the risk that the performance validation tests of the BioSentry Beta units are not successfully completed due to unforeseen issues with the installation and operation of the units outside of the controlled environment of JMAR's facility, delays in completion of the X-ray Microscope and X-ray Nano Probe prototypes and transition to production units, the failure of the technology to perform as predicted, competition from alternative technologies, uncertainties as to the size of the markets , cost and margins for JMAR's products, failure to obtain market acceptance, current or future government regulations affecting the use of JMAR's products, the lack of availability of critical components, the degree of protection from future patents, other risks associated with the development or acquisition of new products or technologies and those risks detailed in the Company's Form 10-Q for the quarter ended September 30, 2005 and its Form 8-K filed on March 30, 2005 with the SEC. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved. JMAR Technologies, Inc. does not assume any duty to publicly update or revise the material contained herein.